HighTower Advisors
TTOO

HighTower Advisors’s T2 Biosystems, Inc TTOO Stock Holding History

HighTower Advisors’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-12
Closed -$9K – 3459
2022
Q2 		$9K Hold
12
– – ﹤0.01% 3077
2022
Q1 		$31K Hold
12
– – ﹤0.01% 3124
2021
Q4 		$31K Sell
12
-2
-14% -$6.96K ﹤0.01% 3070
2021
Q3 		$65K Hold
14
– – ﹤0.01% 2912
2021
Q2 		$84K Hold
14
– – ﹤0.01% 2836
2021
Q1 		$110K Sell
14
-1
-7% -$10.6K ﹤0.01% 2744
2020
Q4 		$90K Hold
15
– – ﹤0.01% 2359
2020
Q3 		$102K Buy
15
+5
+50% +$37.1K ﹤0.01% 2229
2020
Q2 		$62K Buy
10
+3
+43% +$12.7K ﹤0.01% 2185
2020
Q1 		$22K Buy
+7
New +$29.1K ﹤0.01% 2074
2019
Q4 		– Sell
-2
Closed -$25K – 2567
2019
Q3 		$25K Sell
2
-8
-80% -$64.2K ﹤0.01% 2258
2019
Q2 		$79K Buy
10
+1
+11% +$11.7K ﹤0.01% 2185
2019
Q1 		$115K Buy
9
+1
+13% +$17K ﹤0.01% 2048
2018
Q4 		$130K Buy
8
+2
+33% +$47K ﹤0.01% 1930
2018
Q3 		$214K Buy
+6
New +$198K ﹤0.01% 1921

Other funds holding TTOO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

HighTower Advisors's TTOO Position: Q3 2022 in Review

HighTower Advisors sold out of T2 Biosystems, Inc (TTOO) in Q3 2022, closing a stake of 12 shares — an estimated $9K sold.

HighTower Advisors first reported a position in TTOO in Q3 2018 and held it in 15 quarters. The position peaked at $214K in Q3 2018. 54 funds tracked by Wall St. Rank hold TTOO as of Q3 2022.

  • HighTower Advisors reported no remaining T2 Biosystems, Inc position as of Q3 2022 after selling out during the quarter.
  • HighTower Advisors sold 12 T2 Biosystems, Inc shares in Q3 2022, an estimated $9K.
  • HighTower Advisors first reported a position in T2 Biosystems, Inc in Q3 2018 and held it in 15 quarters.
  • HighTower Advisors's T2 Biosystems, Inc position peaked at $214K in Q3 2018.
  • 54 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q3 2022.

Based on HighTower Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.